MindWalk Holdings Corp. (HYFT)
MindWalk Holdings Corp. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
MindWalk Holdings Corp. (HYFT) is a Biotechnology company based in CA with a market capitalization of $82M. Revenue grew 0.0% year-over-year and free cash flow was negative at -$5.1M. This page tracks HYFT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
CA · 102 employees · IPO Jan 7, 2002
Valuation
Valuation & price
$1.65as of May 26, 2026· -48.4% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$82M
Market cap
0.0%
Revenue growth (YoY)
55.3%
Gross margin
-$5.1M
Free cash flow (USD)
$2.7M
Net debt
30.2%
Share dilution
0/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: —
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 6-K filingJul 1, 2026Filing
Patent Filing Announcement
- 6-K filingJun 12, 2026Filing
Participation in AI Panel
- 6-K filingJun 10, 2026Filing
Product Launch
- 6-K filingJun 2, 2026Filing
Preclinical Dengue Data Reported
- 6-K filingMay 27, 2026Filing
Pandemic Response Platform Launch
- 6-K filingMay 18, 2026Filing
Press Release
- 6-K filingMar 31, 2026Filing
Insider Activity Report
Questions
Frequently asked questions
What is MindWalk Holdings Corp.'s market cap?
MindWalk Holdings Corp. (HYFT) has a market capitalization of $82M.
What is HYFT's P/E ratio?
A meaningful P/E ratio is not available for HYFT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
Are insiders buying HYFT stock?
SEC Form 4 filings show no open-market insider buys at MindWalk Holdings Corp. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.